Evidence map›Paper›PMID 29549623›Full record

ArticleInternational urology and nephrology2018

Tonsillitis exacerbates renal injury in IgA nephropathy through promoting Th22 cells chemotaxis.

Lu Gan, Mengyuan Zhu, Xiaozhao Li, Chen Chen, Ting Meng, Jiaxi Pu, Huiming Luo, Fengmin Shao, Qiaoling Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Immune abnormalities in IgA nephropathy.Clinical kidney journal · 2023
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Lu GanDepartment of Nephrology, First People's Hospital of Yunnan Province, Kunming University of Science and Technology, Kunming, Yunnan, China.
Mengyuan ZhuDepartment of Nephrology, People's Hospital of Zhengzhou University, Henan, China.
Xiaozhao LiDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Chen ChenDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ting MengDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jiaxi PuDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Huiming LuoDepartment of Nephrology, First People's Hospital of Yunnan Province, Kunming University of Science and Technology, Kunming, Yunnan, China.
Fengmin ShaoDepartment of Nephrology, People's Hospital of Zhengzhou University, Henan, China.
Qiaoling ZhouDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China. zqling8315@163.com.
Xiangya Hospital Central South University · CNZhengzhou University · CNCentral South University · CNFirst People's Hospital of Yunnan Province · CNKunming University of Science and Technology · CN

Funding

National Natural Science Foundation of China 81270786National Natural Science Foundation of China 81470933
6 · The paper itself

Abstract

backgroundTonsillitis can promote the progression of IgA nephropathy (IgAN) by aggravating immunopathologic response. Th22 cell disorder is involved in the pathogenesis of IgAN with tonsillitis. This study was determined to explore the possible mechanism of IgAN with tonsillitis underlying Th22 cell chemotaxis response to the effect of CCL20, CCL22, and CCL27.

methodsThis research was conducted on 65 subjects including 16 healthy controls (HC group), 5 patients with  renal carcinoma (HTC group) and 44 patients with IgAN between 2015 and 2016. According to clinical symptoms and results of throat swab culture, patients with IgAN were divided into two groups: IgAN with tonsillitis (IgAN + tonsillitis, n = 14) and IgAN patients without tonsillitis (IgAN, n = 30). Distribution of Th22 cells in IgAN patients was determined. The expression of CCL20, CCL22, and CCL27 in both peripheral blood and kidneys of IgAN patients was investigated. Severity of pathological lesions in IgAN patients was analyzed. Coculture assay and transwell assay were performed to explore the impacts of human mesangial cells (HMC) on Th22 cell chemotaxis and Th22 cell local accumulation under hemolytic streptococcus (HS) infection.

resultsTh22 cell percentages in IgAN patients increased compared with healthy controls. This increased Th22 cell percentage was positively correlated with the renal lesions of IgAN patients. Correspondingly, the expression of CCL20, CCL22, and CCL27 in renal tissue increased in IgAN patients. Tonsillitis exacerbated these overrepresentations of Th22 cells and chemokines. It was found that HMC could produce CCL20, CCL22, and CCL27. The supernatant of HMC was chemotactic for Th22 cells. This activity of HMC was stimulated by HS infection, whereas treatment of anti-CCL20, anti-CCL22, and anti-CCL27 antibodies partly blocked this chemoattractant effect of HMC.

conclusionsTonsil infection may aggravate the renal pathological lesions of IgAN by exacerbating Th22 cell accumulation. Our data suggested a collaboration between HMC and Th22 cells in IgAN with tonsillitis underlying the effects of CCL20, CCL22, and CCL27.

Indexed as

Acute Kidney InjuryAdultAnalysis of VarianceBiopsy, NeedleCase-Control StudiesCells, CulturedChemokine CCL22ChemotaxisCoculture TechniquesDisease ProgressionEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryGlomerulonephritis, IGAHumansImmunohistochemistryChemokine CCL22CCL20CCL22CCL27IgA NephropathyTh22 CellsTonsillitis

Identifiers

PMID29549623
OpenAlexW2790707616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.